DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Marriott Wardman Park Hotel

2020 年 01 月 27 日 7:00 上午 - 2020 年 01 月 29 日 4:15 下午

2660 Woodley Road, NW, , Washington, DC 20008 , USA

Pharmacovigilance and Risk Management Strategies Conference

Session 4: Special Safety Considerations in Benefit-Risk Equipoise of Allogeneic Chimeric Antigen Receptor T (alloCAR-T) Cell Therapies

Session Chair(s)

William  Gregory, PhD

William Gregory, PhD

Senior Director, Safety and Risk Management

Pfizer Inc, United States

Session 4: Special Safety Considerations in Benefit-Risk Equipoise of Allogeneic Chimeric Antigen Receptor T (alloCAR-T) Cell Therapies

Speaker(s)

Peter F. Bross, MD

Speaker

Peter F. Bross, MD

FDA, United States

Medical Review Officer OTAT, CBER

William  Gregory, PhD

Speaker

William Gregory, PhD

Pfizer Inc, United States

Senior Director, Safety and Risk Management

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。